Whole Genome Sequencing Market Size, Trends, Share, Growth | Report 2023-2032
The global whole genome sequencing market was surpassed at USD 6.16 billion in 2022 and is expected to hit around USD 33.33 billion by 2032, growing at a CAGR of 18.4% from 2023 to 2032.
Key Pointers
Report Scope of the Whole Genome Sequencing Market
| Report Coverage | Details |
| Market Size in 2022 | USD 6.16 billion |
| Revenue Forecast by 2032 | USD 33.33 billion |
| Growth rate from 2023 to 2032 | CAGR of 18.4% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | GE Healthcare, Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN N.V., Agilent Technologies, 10 x Genomics, BGI, Oxford Nanopore, Nebula Genomics, Veritas Genetics, and GENEWIZ amongst others. |
WGS is comparatively more recent than targeted sequencing and resequencing, and its implementation is getting simpler as high capacity sequencing technologies are developed. Applications for WGS include genome, microbial resequencing, and de novo genome sequencing. It is projected that it will expand significantly. A rise in the usage of this technology against COVID-19 is expected to drive the market growth. For instance, in March 2022, an article published in Frontiers claimed that WGS may be used to identify SARS-CoV-2 Infection. Furthermore, it helped pediatric oncology patients in differentiating between hospital- and community-acquired infections. Moreover, in December 2022, the Department of Defense developed a SARS-CoV-2 Whole Genome Sequencing Action Plan for the Military Health System in response to the COVID-19 pandemic. In accordance with the strategy, whole genome sequencing will be carried out throughout the MHS by the service laboratories.
This sequencing technology has wide clinical applications. It is attractive for clinical use because it encompasses sections of the genome that can be changed to find differences in the exon regions and uncover causal variants of a disease or disease-causing mutations. The production of WES data on a population level has increased significantly. The Miller Syndrome, Mendelian phenotypes, and complex disease genes were found using the WES, demonstrating its successful applicability in this area.
In addition, companies like Illumina provides microbial WGS as the first NGS technique applicable to the surveillance of infectious diseases. Such technology can deliver quick results and high-quality data. It can also be used to locate, monitor, and address disease outbreaks in a region. WGS is shown to be most useful in research and rarely in therapeutic applications. The market players are also engaged in a number of current projects, which accelerates the adoption of WGS.
Several initiatives by key market players and ongoing technological advancement are likely to create opportunities for market growth. For instance, in November 2022, using Nanopore Genome Sequencing, AI, and Cloud Computing, Stanford Medicine scientists sequence a patient's whole genome in under five hours. They also identified a child with a rare genetic disease in less than eight hours. On the other hand, in November 2021, Illumina and Genetic Alliance announced a USD 120 million global initiative—iHope Genetic Health program. This initiative aims to offer WGS access to various patients impacted by genetic disorders globally.
Whole Genome Sequencing Market Segmentations:
| By Sequencing Type | By Product Type | By Application | By End User |
|
Large Whole-Genome Sequencing Small Genome Sequencing |
Instrument Kits Service |
Diagnostics Drug Discovery and Development Personalized Medicine Others |
Hospitals and Clinics Pharmaceutical and Biotechnology Companies Others |
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Whole Genome Sequencing Market
5.1. COVID-19 Landscape: Whole Genome Sequencing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Whole Genome Sequencing Market, By Sequencing Type
8.1. Whole Genome Sequencing Market, by Sequencing Type, 2023-2032
8.1.1. Large Whole-Genome Sequencing
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Small Genome Sequencing
8.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Whole Genome Sequencing Market, By Product Type
9.1. Whole Genome Sequencing Market, by Product Type, 2023-2032
9.1.1. Instrument
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Kits
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Service
9.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Whole Genome Sequencing Market, By Application
10.1. Whole Genome Sequencing Market, by Application, 2023-2032
10.1.1. Diagnostics
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Drug Discovery and Development
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Personalized Medicine
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Others
10.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Whole Genome Sequencing Market, By Hospitals and Clinics
11.1. Whole Genome Sequencing Market, by End User, 2023-2032
11.1.1. Hospitals and Clinics
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Pharmaceutical and Biotechnology Companies
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Others
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Whole Genome Sequencing Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Sequencing Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Product Type (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Thermo Fisher Scientific, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Illumina, Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. QIAGEN N.V.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Agilent Technologies
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. 10 x Genomics
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. BGI
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Oxford Nanopore
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Nebula Genomics
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Veritas Genetics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers